Abstract
Fear is a conscious state caused by exposure to real or imagined threats that trigger stress responses that affect the body and brain, particularly limbic structures. A sub-group of patients with mesial temporal lobe epilepsy related to hippocampus sclerosis (MTLE-HS) have seizures with fear, which is called ictal fear (IF), due to epileptic activity within the brain defensive survival circuit structures. Synaptic transmission efficacy can be bi-directionally modified through potentiation (long-term potentiation (LTP)) or depression (long-term depression (LTD)) as well as the phosphorylation state of Ser831 and Ser845 sites at the GluA1 subunit of the glutamate AMPA receptors, which has been characterized as a critical event for this synaptic plasticity. In this study, GluA1 levels and the phosphorylation at Ser845 and Ser831 in the amygdala (AMY), anterior hippocampus (aHIP) and middle gyrus of temporal neocortex (CX) were determined with western blots and compared between MTLE-HS patients who were showing (n = 06) or not showing (n = 25) IF. Patients with IF had an 11% decrease of AMY levels of the GluA1 subunit (p = 0.05) and a 21.5% decrease of aHIP levels of P-GluA1-Ser845 (p = 0.009) compared to patients not showing IF. The observed associations were not related to imbalances in the distribution of other concomitant types of aura, demographic, clinical or neurosurgical variables. The lower levels of P-GluA1-Ser845 in the aHIP of patients with IF were not related to changes in the levels of the serine/threonine-protein phosphatase PP1-alpha catalytic subunit or protein kinase A activation. Taken together, the GluA1 subunit levels in AMY and P-GluA1-Ser845 levels in the aHIP show an overall accuracy of 89.3% (specificity 95.5% and sensitivity 66.7%) to predict the presence of IF. AMY levels of the GluA1 subunit and aHIP levels of P-GluA1-Ser845 were not associated with the psychiatric diagnosis and symptoms of patients. Taken together with previous findings in MTLE-HS patients with IF who were evaluated by stereotactic implanted depth electrodes, we speculate our findings are consistent with the hypothesis that AMY is not a centre of fear but together with other sub-cortical and cortical structures integrates the defensive circuit that detect and respond to threats. This is the first report to address neuroplasticity features in human limbic structures connected to the defensive survival circuits, which has implications for the comprehension of highly prevalent psychiatric disorders and symptoms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Izquierdo I,Furini CRG,Myskiw JC, Fear memory. Physiol Rev. 2016;92:695–750.
LeDoux JE, Pine DS. Using neuroscience to help understand fear and anxiety: A two-system framework. Am J Psychiatry. 2016;173:1083–93.
Sapolsky RM. Stress and the brain: individual variability and the inverted-U. Nat Neurosci. 2015;18:1344–6.
Walz R,Maria R,Castro RPS,Velasco TR,Jr,Carlotti CG,Sakamoto C, et al. Cellular prion protein: implications in seizures and epilepsy. Cell Mol Neurobiol. 2002;22:249–57.
Jefferys JGR. Models and mechanisms of experimental epilepsies. Epilepsia. 2003;44:44–50.
Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313:285–93.
Pauli C, de Oliveira Thais MER, Guarnieri R, Schwarzbold ML, Diaz AP, Ben J, et al. Decline in word-finding: the objective cognitive finding most relevant to patients after mesial temporal lobe epilepsy surgery. Epilepsy Behav. 2017;75:218–24.
Pauli C, Schwarzbold ML, Diaz AP, de Oliveira Thais MER, Kondageski C, Linhares MN, et al. Predictors of meaningful improvement in quality of life after temporal lobe epilepsy surgery: a prospective study. Epilepsia. 2017;58:755–63.
Wiebe S,Blume WT,Girvin JP,Eliasziw M,Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.
Gotman J, Levtova V. Amygdala-hippocampus relationships in temporal lobe seizures: a phase-coherence study. Epilepsy Res. 1996;25:51–57.
Bartolomei F, Lagarde S, Wendling F, Mcgonigal A, Jirsa V, Guye M, et al. Defining epileptogenic networks: contribution of SEEG and signal analysis. Epilepsia. 2017;58:1131–47.
Muhlhofer W, Tan YL, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-What do we know? Epilepsia. 2017;58:727–42.
Cendes F,Andermann F,Gloor P,Gambardella A,Lopes-Cendes I,Watson C, et al. Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy. Brain. 1994;117:739–46.
Feichtinger M, Pauli E, Schäfer I, Eberhardt KW, Tomandl B, Huk J, et al. Ictal fear in temporal lobe epilepsy. Arch Neurol. 2001;58:771–7.
Biraben A, Taussig D, Thomas P, Even C, Vignal JP, Scarabin JM, et al. Fear as the main feature of epileptic seizures. J Neurol Neurosurg Psychiatry. 2001;70:186–91.
Bartolomei F, Trébuchon A, Gavaret M, Régis J, Wendling F, Chauvel P. Acute alteration of emotional behaviour in epileptic seizures is related to transient desynchrony in emotion-regulation networks. Clin Neurophysiol. 2005;116:2473–9.
Bear MF. A synaptic basis for memory storage in the cerebral cortex. Proc Natl Acad Sci USA. 1996;93:13453–13459.
Nabavi S, Fox R, Proulx CD, Lin JY, Tsien RY, Malinow R. Engineering a memory with LTD and LTP. Nature. 2014;511:348–52.
Jerusalinsky D, Ferreira MBC, Walz R, Da Silva RC, Bianchin M, Ruschel AC, et al. Amnesia by post-training infusion of glutamate receptor antagonists into the amygdala, hippocampus, and entorhinal cortex. Behav Neural Biol. 1992;58:76–80.
Izquierdo I, Medina JH, Bianchin M, Walz R, Zanatta MS, Da Silva RC, et al. Memory processing by the limbic system: role of specific neurotransmitter systems. Behav Brain Res. 1993;58:91–8.
Walz R, Roesler R, Quevedo J, Sant’Anna MK, Madruga M, Rodrigues C, et al. Time-dependent impairment of inhibitory avoidance retention in rats by posttraining infusion of a mitogen-activated protein kinase kinase inhibitor into cortical and limbic structures. Neurobiol Learn Mem. 2000;73:11–20.
Jerusalinsky D, Quillfeldt JA, Walz R, Da Silva RC, Medina JH, Izquierdo I. Post-training intrahippocampal infusion of protein kinase C inhibitors causes amnesia in rats. Behav Neural Biol. 1994;61:107–9.
Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long term potentiation in the hippocampus. Science. 2006;313:1093–7.
Henley JM, Wilkinson KA. Synaptic AMPA receptor composition in development, plasticity and disease. Nat Rev Neurosci. 2016;17:337–50.
Huganir RL, Nicoll RA. AMPARs and synaptic plasticity: the last 25 years. Neuron. 2013;80:704–17.
Wang JQ, Guo M-L, Jin D-Z, Xue B, Fibuch EE, Mao LM. Roles of subunit phosphorylation in regulating glutamate receptor function. Eur J Pharmacol. 2014;728:183–7.
Woolfrey KM, Dell’Acqua ML. Coordination of protein phosphorylation and dephosphorylation in synaptic plasticity. J Biol Chem. 2015;290:28604–12.
Esteban JA, Shi S-H, Wilson C, Nuriya M, Huganir RL, Malinow R. PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci. 2003;6:136–43.
Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature. 2000;405:955–9.
Lopes MW, Leal RB, Guarnieri R, Schwarzbold ML, Hoeller A, Diaz AP, et al. A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system. Transl Psychiatry. 2016;6:e986.
Strange BA, Witter MP, Lein ES, Moser EI, Functional organization of the hippocampal longitudinal axis. Nat Rev Neurosci. 2014;15:655–69.
Araújo D, Santos AC, Velasco TR, Wichert-Ana L, Terra-Bustamante VC, Alexandre V Jr., et al. Volumetric evidence of bilateral damage in unilateral mesial temporal lobe epilepsy. Epilepsia. 2006;47:1354–9.
Guarnieri R, Walz R, Hallak JEC, Coimbra A, de Almeida E, Cescato MP, et al. Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery? Epilepsy Behav. 2009;14:529–34.
Nunes JC, Zakon DB, Claudino LS, Guarnieri R, Bastos A, Queiroz LP, et al. Hippocampal sclerosis and ipsilateral headache among mesial temporal lobe epilepsy patients. Seizure. 2011;20:480–4.
Velasco TR, Wichert-Ana L, Mathern GW, Araújo D, Walz R, Bianchin MM, et al. Utility of ictal single photon emission computed tomography in mesial temporal lobe epilepsy with hippocampal atrophy: a randomized trial. Neurosurgery. 2011;68:431–6.
de Lemos Zingano B, Guarnieri R, Diaz AP, Schwarzbold ML, Bicalho MAH, Claudino LS, et al. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav. 2015;50:61–6.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009;51:1069–77.
First M, Spitzer R, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders Clinical Version (SCID-CV). Washington: American Psychiatric Press; 1996.
Krishnamoorthy ES, Trimble MR, Blumer D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav. 2007;10:349–53.
Logsdail SJ, Toone BK. Post-ictal psychoses. A clinical and phenomenological description. Br J Psychiatry. 1988;152:246–52.
Pauli C, Thais ME, de O, Claudino LS, Bicalho MAH, Bastos AC,Guarnieri R, et al. Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy. Epilepsy Behav. 2012;25:208–13.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer Biomark. 2010;9:531–49.
Ronsoni MF, Remor AP, Lopes MW, Hohl A, Troncoso IHZ, Leal RB, et al. Mitochondrial respiration chain enzymatic activities in the human brain: methodological implications for tissue sampling and storage. Neurochem Res. 2016;41:880–91.
Lopes MW, Soares FMS, De Mello N, Nunes JC, Cajado AG, De Brito D, et al. Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy. Exp Brain Res. 2013;226:153–63.
Lopes MW, Lopes SC, Costa AP, Gonçalves FM, Rieger DK, Peres TV, et al. Region-specific alterations of AMPA receptor phosphorylation and signaling pathways in the pilocarpine model of epilepsy. Neurochem Int. 2015;87:22–33.
Lopes MW, Soares FMS, de Mello N, Nunes JC, de Cordova FM, Walz R, et al. Time-dependent modulation of mitogen activated protein kinases and AKT in rat hippocampus and cortex in the pilocarpine model of epilepsy. Neurochem Res. 2012;37:1868–78.
Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346–56.
Seo SY, Oh JH, Choe ES. Protein kinase G increases AMPA receptor GluR1 phosphorylation at serine 845 after repeated cocaine administration in the rat nucleus accumbens. Neurosci Lett. 2013;544:147–51.
Din NU, Ahmad I, Haq IU, Elahi S, Hoessli DC, Shakoori AR. The function of GluR1 and GluR2 in cerebellar and hippocampal LTP and LTD is regulated by interplay of phosphorylation and O-GlcNAc modification. J Cell Biochem. 2010;109:585–97.
Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35:169–91.
Bevilaqua LR, Medina JH, Izquierdo I, Cammarota M. Memory consolidation induces N-methyl-D-aspartic acid-receptor- and Ca 2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties. Neuroscience. 2005;136:397–403.
Shukla K, Kim J, Blundell J, Powell CM. Learning-induced glutamate receptor phosphorylation resembles that induced by long term potentiation. J Biol Chem. 2007;282:18100–7.
Roche KW, O’Brien RJ, Mammen AL, Bernhardt J, Huganir RL. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron. 1996;16:1179–88.
Derkach V, Barria A, Soderling TR. Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA. 1999;96:3269–74.
Ehlers MD. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron. 2000;28:511–25.
Lee HK, Kameyama K, Huganir RL, Bear MF. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron. 1998;21:1151–62.
Cammarota M, Bernabeu R, Levi De Stein M, Izquierdo I, Medina JH. Learning-specific, time-dependent increases in hippocampal Ca2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity. Eur J Neurosci. 1998;10:2669–76.
LeDoux JE. Coming to terms with fear. Proc Natl Acad Sci USA. 2014;111:2871–8.
Rodrigues SM, LeDoux JE, Sapolsky RM. The influence of stress hormones on fear circuitry. Proc Natl Acad Sci USA. 2014;111:2871–8.
Kim JJ, Diamond DM, Haven N, Blvd BBD. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci. 2002;3:453–62.
Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925–35.
Boutros NN, Gjini K, Moran J, Chugani H, Bowyer S. Panic versus epilepsy: a challenging differential diagnosis. Clin EEG Neurosci. 2013;44:313–8.
Gerez M, Sada A, Tello A. Amygdalar hyperactivity, a fear-related link between panic disorder and mesiotemporal epilepsy. Clin EEG Neurosci. 2011;42:29–39.
Adamaszek M, Olbrich S, Gallinat J. The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder. Clin EEG Neurosci. 2011;42:166–74.
Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54:1315–29.
Yilmazer-Hanke DM, Wolf HK, Schramm J, Elger CE, Wiestler OD, Blümcke I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J Neuropathol Exp Neurol. 2000;59:907–20.
Acknowledgements
This work was supported by PRONEX Program (Programa de Núcleos de Excelência–NENASC Project) of FAPESC-CNPq-MS, Santa Catarina Brazil (process 56802/2010). MRC 271-05-0712 (ZAB) and FAPESC-CONFAP–THE UK ACADEMIES–2016 (ZAB and RW). Professor Dr. Peter Wolf is Special Visitor Researcher (Process 88881.030478/2013-01) supported by MEC/MCTI/CAPES/CNPq/FAPs. We thank David Lodge (School of Physiology, Pharmacology and Neuroscience, University of Bristol) for the English revision. RBL, AL, RDP, KL and RW are researchers from the Brazilian National Council for Scientific and Technological Development (CNPq). RBL and RW dedicate this work to Professor Dr. Ivan A. Izquierdo for his teachings about neurobiology of aversive memory and “in memoriam” to Professor Dr. Richard Rodnight for his teachings in phospho-proteins and signal transduction.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
These authors contributed equally: Rodrigo Bainy Leal, Mark William Lopes.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Leal, R.B., Lopes, M.W., Formolo, D.A. et al. Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety. Mol Psychiatry 25, 655–665 (2020). https://doi.org/10.1038/s41380-018-0084-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-018-0084-7
This article is cited by
-
Pharmacological Evidence of Eugenia Brasiliensis Leaves in a Reserpine-Induced Fibromyalgia Model: Antinociceptive, Emotional, Anti-Inflammatory, and Neurotrophic Effects
Molecular Neurobiology (2024)
-
Clinical Correlation of Altered Molecular Signatures in Epileptic Human Hippocampus and Amygdala
Molecular Neurobiology (2024)
-
A neuronal social trait space for first impressions in the human amygdala and hippocampus
Molecular Psychiatry (2022)
-
The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats
Molecular Psychiatry (2021)
-
AMPAr GluA1 Phosphorylation at Serine 845 in Limbic System Is Associated with Cardiac Autonomic Tone
Molecular Neurobiology (2021)